Latest Ratios: P/E Ratio 32.3x · EV/EBITDA 18.8x · ROE 17.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $23.1B | $20.5B | $25.9B | $23.4B | $19.9B | $25.6B | $22.0B | $17.7B | $16.5B | $12.8B | $11.6B |
| Enterprise Value | $24.9B | $22.3B | $27.3B | $25.7B | $22.4B | $28.1B | $24.2B | $19.8B | $18.3B | $14.9B | $12.5B |
| P/E Ratio → | 32.27 | 27.76 | 44.18 | 31.00 | 47.98 | 30.87 | 27.96 | 28.83 | 28.97 | 17.30 | 25.25 |
| P/S Ratio | 3.72 | 3.30 | 4.23 | 3.99 | 3.69 | 4.93 | 4.49 | 4.07 | 3.98 | 3.40 | 3.32 |
| P/B Ratio | 5.95 | 5.12 | 5.93 | 6.07 | 5.69 | 7.91 | 7.28 | 6.65 | 6.72 | 5.79 | 5.86 |
| P/FCF | 21.12 | 18.74 | 26.48 | 29.01 | 28.11 | 29.24 | 24.68 | 22.42 | 23.44 | 20.19 | 19.13 |
| P/OCF | 18.99 | 16.85 | 22.36 | 22.72 | 22.43 | 25.74 | 22.21 | 20.51 | 21.59 | 18.85 | 17.67 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.59 | 4.47 | 4.38 | 4.17 | 5.41 | 4.94 | 4.54 | 4.41 | 3.96 | 3.58 |
| EV / EBITDA | 18.78 | 16.82 | 26.09 | 20.02 | 27.46 | 21.63 | 19.82 | 19.48 | 19.59 | 17.42 | 15.05 |
| EV / EBIT | 23.09 | 21.18 | 32.06 | 23.81 | 36.60 | 25.85 | 23.36 | 23.37 | 22.88 | 20.05 | 17.06 |
| EV / FCF | — | 20.38 | 27.95 | 31.81 | 31.75 | 32.09 | 27.12 | 25.04 | 25.99 | 23.48 | 20.67 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.7% | 44.7% | 45.7% | 44.1% | 41.9% | 43.6% | 45.2% | 45.5% | 44.4% | 45.8% | 45.5% |
| Operating Margin | 17.4% | 17.4% | 13.2% | 18.0% | 11.1% | 20.8% | 21.0% | 19.3% | 19.1% | 19.4% | 20.7% |
| Net Profit Margin | 11.9% | 11.9% | 9.6% | 12.9% | 7.7% | 15.9% | 16.1% | 14.1% | 13.7% | 19.7% | 13.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 17.6% | 17.6% | 14.2% | 20.6% | 12.3% | 26.5% | 27.6% | 24.1% | 24.3% | 35.4% | 22.9% |
| ROA | 8.3% | 8.3% | 6.7% | 8.9% | 5.1% | 10.7% | 11.2% | 9.7% | 9.4% | 14.3% | 10.7% |
| ROIC | 13.9% | 13.9% | 10.2% | 13.0% | 7.6% | 14.8% | 15.6% | 14.0% | 13.9% | 15.2% | 19.2% |
| ROCE | 14.4% | 14.4% | 11.0% | 14.8% | 9.1% | 18.1% | 17.8% | 16.3% | 16.1% | 17.4% | 21.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.55 | 0.55 | 0.68 | 0.82 | 0.85 | 0.78 | 0.83 | 0.86 | 1.07 | 0.57 |
| Debt / EBITDA | 1.66 | 1.66 | 2.30 | 2.03 | 3.49 | 2.11 | 1.93 | 2.19 | 2.26 | 2.77 | 1.35 |
| Net Debt / Equity | — | 0.45 | 0.33 | 0.59 | 0.74 | 0.77 | 0.72 | 0.78 | 0.73 | 0.94 | 0.47 |
| Net Debt / EBITDA | 1.36 | 1.36 | 1.38 | 1.76 | 3.15 | 1.92 | 1.78 | 2.03 | 1.92 | 2.44 | 1.12 |
| Debt / FCF | — | 1.64 | 1.48 | 2.80 | 3.65 | 2.85 | 2.44 | 2.61 | 2.55 | 3.29 | 1.54 |
| Interest Coverage | 11.05 | 11.05 | 8.96 | 9.72 | 6.84 | 19.93 | 16.96 | 11.51 | 10.06 | 14.17 | 26.48 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | 1.07 | 1.70 | 1.08 | 1.18 | 0.59 | 0.80 | 0.88 | 0.81 | 1.07 | 0.76 |
| Quick Ratio | 0.71 | 0.71 | 1.24 | 0.64 | 0.63 | 0.34 | 0.44 | 0.49 | 0.52 | 0.72 | 0.50 |
| Cash Ratio | 0.27 | 0.27 | 0.73 | 0.24 | 0.23 | 0.12 | 0.13 | 0.14 | 0.24 | 0.30 | 0.19 |
| Asset Turnover | — | 0.70 | 0.69 | 0.68 | 0.64 | 0.65 | 0.66 | 0.65 | 0.68 | 0.63 | 0.80 |
| Inventory Turnover | 6.41 | 6.41 | 5.41 | 5.35 | 4.83 | 5.47 | 5.41 | 5.69 | 6.02 | 6.19 | 7.37 |
| Days Sales Outstanding | — | 34.92 | 35.91 | 32.77 | 28.65 | 28.52 | 29.73 | 29.85 | 30.40 | 33.43 | 29.99 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.2% | 1.4% | 1.1% | 1.1% | 1.3% | 1.0% | 1.1% | 1.3% | 1.3% | 1.5% | 1.6% |
| Payout Ratio | 39.0% | 39.0% | 47.3% | 35.3% | 61.6% | 29.9% | 30.2% | 36.4% | 37.5% | 25.6% | 39.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.1% | 3.6% | 2.3% | 3.2% | 2.1% | 3.2% | 3.6% | 3.5% | 3.5% | 5.8% | 4.0% |
| FCF Yield | 4.7% | 5.3% | 3.8% | 3.4% | 3.6% | 3.4% | 4.1% | 4.5% | 4.3% | 5.0% | 5.2% |
| Buyback Yield | 3.9% | 4.4% | 0.0% | 1.3% | 0.0% | 2.0% | 1.4% | 1.4% | 1.2% | 3.1% | 3.5% |
| Total Shareholder Yield | 5.1% | 5.8% | 1.1% | 2.4% | 1.3% | 2.9% | 2.4% | 2.7% | 2.5% | 4.6% | 5.0% |
| Shares Outstanding | — | $244M | $247M | $248M | $246M | $250M | $252M | $252M | $251M | $256M | $262M |
M&A Integration Leverage
According to current market data, CHD trades at a 32.91x trailing P/E, a valuation that appears to price in significant future accretion from its M&A-heavy strategy rather than the organic growth profile typically associated with the broader consumer defensive sector's more modest valuation multiples.
The elevated P/E ratio relative to peers like Procter & Gamble suggests that investors are paying a premium for the company's ability to integrate niche brands into its distribution network. This valuation warrants caution, as it implies that any deceleration in acquisition-led growth could lead to a significant multiple contraction.
Based on reported figures, ROIC has hovered in the 3-4% range over recent quarters, a trend that suggests the company's aggressive acquisition strategy is currently diluting the efficiency of invested capital compared to more organic, asset-light competitors within the household products industry.
The persistent gap between ROIC and historical benchmarks indicates that the integration of acquired intangible assets is not yet yielding the expected returns on invested capital. Investors should monitor whether management can improve these returns as recent acquisitions like Hero Cosmetics reach full operational maturity.
As reported in financial statements, the cash conversion cycle has fluctuated between 16 and 30 days over the last ten quarters, reflecting the inherent challenges of managing inventory and receivables across a diverse portfolio of consumer goods that rely heavily on large-scale retail distribution channels.
The variability in the CCC suggests that the company's working capital management is sensitive to retailer inventory policies and promotional timing. This volatility may indicate that the company lacks the absolute bargaining power to dictate terms to its largest retail partners, potentially impacting short-term liquidity.
According to recent SEC filings, the debt-to-EBITDA ratio of 7.58x in 2026Q1 highlights a reliance on leverage to fund growth, though the interest coverage ratio of 12.12x suggests that the company maintains sufficient earnings power to service its obligations under current interest rate environments.
While the leverage profile appears manageable, the reliance on debt to fuel M&A activity creates a structural sensitivity to credit market conditions. Any sustained increase in borrowing costs could compress net margins, as the company's debt-to-equity ratio remains elevated compared to more conservative peers.
Based on an analysis of the company's business model, the P/E ratio is frequently misapplied by investors who fail to adjust for the heavy amortization of acquired brand equity, which artificially depresses reported earnings and obscures the underlying cash-generating potential of the firm's core power brands.
Analysts should prioritize EV/EBITDA or P/FCF metrics to better capture the true operational performance of the business. Relying solely on P/E ignores the non-cash nature of acquisition-related charges that are central to the company's growth strategy, leading to a potentially distorted view of its valuation.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CHD stock.
Church & Dwight Co., Inc.'s current P/E ratio is 32.3x. The historical average is 25.1x. This places it at the 93th percentile of its historical range.
Church & Dwight Co., Inc.'s current EV/EBITDA is 18.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.1x.
Church & Dwight Co., Inc.'s return on equity (ROE) is 17.6%. The historical average is 19.2%.
Based on historical data, Church & Dwight Co., Inc. is trading at a P/E of 32.3x. This is at the 93th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Church & Dwight Co., Inc.'s current dividend yield is 1.21% with a payout ratio of 39.0%.
Church & Dwight Co., Inc. has 44.7% gross margin and 17.4% operating margin. Operating margin between 10-20% is typical for established companies.
Church & Dwight Co., Inc.'s Debt/EBITDA ratio is 1.7x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.